Molecular Formula: C6H13NO2
Molecular weight: 131.17 g/mol
CAS No: 60-32-2
ATC Code: B02AA01
Drug Class: Anti-Fibrinolytic
General Properties:
6-aminohexanoic acid is an epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator. It has a role as an antifibrinolytic drug, a hematologic agent and a metabolite. It is an epsilon-amino acid and an omega-amino fatty acid. It is functionally related to a hexanoic acid. It is a conjugate acid of a 6-aminohexanoate. It is a tautomer of a 6-aminohexanoic acid zwitterion.
An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
Aminocaproic acid is an Antifibrinolytic Agent. The physiologic effect of aminocaproic acid is by means of Decreased Fibrinolysis.
Indication:
Aminocaproic acid, an antifibrinolytic agent, is approved by the U.S. Food and Drug Administration (FDA) for managing and treating acute bleeding disorders resulting from elevated fibrinolytic activity.
